# US 2004/0203073 A1 · ATP-binding transporter (ABC7) and method for detection of Anemia and Ataxia

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0203073 A1
- Document ID: US20040203073A1
- Status: Published application
- Kind: A1
- Application number: 10/762,596
- Filed: 2004-01-21
- Published: 2004-10-14
- Earliest claimed: 1998-10-23
- Assignees: The Govt. of the U.S.A. as represented by the Secretary of the Dept. of Health & Human Services
- Inventors: Michael C. Dean; Amy Ann Hutchinson; Rando Lembit Allikmets
- Web page: https://patentgrep.com/patent/US20040203073A1

## CPC

- C07H 21/04: with deoxyribosyl as saccharide radical
- C07K 14/705: Receptors; Cell surface antigens; Cell surface determinants {(tumour specific antigens C07K14/4748)}
- C12N 2799/027: where the vector is derived from a retrovirus
- G01N 2333/705: Assays involving receptors, cell surface antigens or cell surface determinants
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Disclosed are a novel ATP-binding cassette gene (ABC7), polypeptide and methods of detecting mutations therein. Further, the disclosure provides methods of detecting ABC7 associated disease and treatments thereof. In particular, the disclosure provides methods of detecting X-linked Sideroblastic Anemia and Ataxia associated with a mutation in the ABC7 polypeptide.

## Claims

### Claim 1

An antibody that binds to a polypeptide comprising an amino acid sequence as set forth in SEQ ID NO: 2 or SEQ ID NO: 4, or a fragment of said polypeptide.

### Claim 2 (depends on 1)

The antibody of claim 1, wherein the polypeptide is from a mammal.

### Claim 3 (depends on 2)

The antibody of claim 2, wherein the polypeptide is from a human.

### Claim 4 (depends on 1)

The antibody of claim 1, wherein the antibody is monoclonal.

### Claim 5 (depends on 1)

The antibody of claim 1, wherein the antibody is polyclonal.

### Claim 6 (depends on 1)

The antibody of claim 1, wherein the antibody is an antibody fragment.

### Claim 7 (depends on 1)

The antibody of claim 1, wherein the antibody is detectably labeled.

### Claim 8 (depends on 7)

The antibody of claim 7, wherein the label is a radioisotope, a bioluminescent compound, a chemiluminescent compound, a fluorescent compound, a metal chelate, a phosphorescent compound, or an enzyme.

### Claim 9 (depends on 1)

The antibody of claim 1, wherein the antibody is bound to a carrier.

### Claim 10 (depends on 9)

The antibody of claim 9, wherein the carrier is glass, polystyrene, polypropylene, polyethylene, dextran, nylon, amylase, cellulose, polyacrylamide, agarose or magnetite.

### Claim 11 (depends on 1)

The antibody of claim 1, wherein the antibody is coupled to a hapten.

### Claim 12 (depends on 11)

The antibody of claim 11, wherein the hapten is biotin, dinitrophenyl, puridoxal, or fluorescein.

### Claim 13 (depends on 1)

The antibody of claim 1, wherein the epitope to which the antibody binds comprises at least amino acid residue 395 of SEQ ID NO: 2 or 4.

### Claim 14 (depends on 13)

The antibody of claim 13, wherein the epitope to which the antibody binds comprises at least amino acid residue 395 of SEQ ID NO: 4.

### Claim 15 (depends on 1)

The antibody of claim 1, which binds to a polypeptide comprising an amino acid sequence as set forth in SEQ ID NO: 2.

### Claim 16 (depends on 1)

The antibody of claim 1, which binds to a polypeptide comprising an amino acid sequence as set forth in SEQ ID NO: 4.

### Claim 17 (depends on 15)

The antibody of claim 15, which does not bind to a polypeptide comprising an amino acid sequence as set forth in SEQ ID NO: 4.

### Claim 18 (depends on 16)

The antibody of claim 16, which does not bind to a polypeptide comprising an amino acid sequence as set forth in SEQ ID NO: 2

### Claim 19 (depends on 18)

The antibody of claim 18, which detects an 1395M mutation.

### Claim 20

An antibody that binds to a mutant ABC7 polypeptide, wherein the polypeptide is expressed in a subject having, or at risk for having, X-linked Sideroblastic Anemia and Ataxia.

### Claim 21 (depends on 20)

The antibody of claim 20, wherein the mutant ABC7 polypeptide comprises an amino acid sequence as set forth in SEQ ID NO: 4.

### Claim 22 (depends on 21)

The antibody of claim 21, wherein the antibody detects an 1395M mutation in the mutant ABC7 polypeptide.

### Claim 23 (depends on 20)

The antibody of claim 20, wherein the antibody is monoclonal.

### Claim 24 (depends on 20)

The antibody of claim 20, wherein the antibody is polyclonal.

### Claim 25 (depends on 20)

The antibody of claim 20, wherein the antibody is an antibody fragment.

### Claim 26 (depends on 1)

A kit useful for the detection of an ATP-binding transporter-7 (ABC7) polypeptide comprising carrier means containing therein one or more containers wherein a first container contains an antibody of claim 1.

### Claim 27 (depends on 26)

The kit of claim 26, wherein the antibody is detectably labeled.

### Claim 28 (depends on 27)

The kit of claim 27, wherein the label is selected from the group consisting of radioisotope, a bioluminescent compound, a chemiluminescent compound, a fluorescent compound, a metal chelate, and an enzyme.
